PGK1 Antibody Validation: Glycolysis Enzyme Detection with Confirmed IHC Data
Why Is PGK1 Detection Difficult to Standardize?
When performing PGK1 detection, a common contrast is observed. Samples with high glycolytic activity show signals so strong that repeated dilutions are needed. This applies to red blood cells and muscle in particular. Some cell lines, by contrast, barely show any bands. The wide expression range of PGK1, along with its potential localization in both cytoplasm and mitochondria, makes species coverage and dilution range of antibodies particularly critical.
The mechanisms, challenges, and a set of verifiable reference data are summarized below.
What Is PGK1?
PGK1, or phosphoglycerate kinase 1, is also known by molecular aliases such as PGKA and PRP 2. It is a cytoplasmic enzyme encoded by the X chromosome. It catalyzes the transfer of a high-energy phosphate group from 1,3-bisphosphoglycerate to ADP, generating ATP and 3-phosphoglycerate. This is one of the two substrate-level phosphorylation steps in glycolysis and the direct ATP-producing step in this pathway.
Beyond its classic metabolic role, PGK1 also has moonlighting functions. Under hypoxia or oncogenic signals, it translocates to mitochondria, phosphorylates pyruvate dehydrogenase kinase 1, or PDHK1, inhibits pyruvate oxidation, and promotes the Warburg effect. It also interacts with Beclin-1 and ATG proteins to initiate autophagy. The product page labels its cellular localization as cytoplasm and mitochondrion, with sequences traceable to UniProt accession P00558.
What Diseases Are Associated With PGK1?
Evidence in hereditary enzymopathies is more definitive. Germline loss-of-function mutations in the PGK1 gene cause an X-linked recessive disorder. It presents with chronic nonspherocytic hemolytic anemia, myopathy, rhabdomyolysis, neurodevelopmental delays, and epilepsy. The common mechanism is impaired ATP generation in red blood cells and muscle. These cell types rely heavily on glycolysis for energy, so the consequences of reduced enzyme activity are direct and pronounced.
In cancer metabolism, PGK1 has become a hot topic. Overexpression or activating post-translational modifications of PGK1 are observed in many malignancies. They are accompanied by enhanced aerobic glycolysis, chemotherapy resistance, increased metastatic potential, and poor prognosis. This positions PGK1 as both a biomarker and a potential target for metabolic intervention.
One caveat applies here. PGK1 participates in the most fundamental ATP-generating steps, so systemic inhibition may affect normal tissue metabolism. Research therefore focuses more on its dependency in specific tumor contexts.
What Technical Challenges Complicate PGK1 Detection?
Three technical issues recur in PGK1 experiments.
Wide expression range makes it hard to use a single condition for all samples. PGK1 is highly abundant in red blood cells, muscle, and some metabolically active tumor cells, while its expression is low in other samples. Using the same dilution ratio for high-abundance samples can lead to signal saturation or elevated background, while low-abundance samples may show almost no bands. Starting with high-expression samples to determine loading amounts and exposure ranges, then adjusting for low-expression samples, usually saves more samples than the reverse approach.
Band position deviates from predicted molecular weight. The product page lists the predicted molecular weight of PGK1 as 45 kDa, but observed values are 40 kDa in A-431, NCCIT, PC-3, HeLa, and Jurkat whole-cell lysates. The observed value is 42 kDa in mouse and rat testis lysates. Relying solely on the predicted value for interpretation may lead to misreading of actual bands, so experimental design should account for this deviation.
Dual localization and endogenous background crossover form the third constraint. PGK1 localizes to both cytoplasm and mitochondria. In immunohistochemistry, metabolically active tissues like liver and kidney inherently show strong signals. If antigen retrieval conditions or antibody concentrations are mismatched, specific staining and background staining can easily overlap.
Immunohistochemistry validation of PGK1 in paraffin-embedded human kidney tissue at 1:2000 dilution
What Parameters and Validation Data Support PGK1 Research?
A mouse monoclonal antibody against PGK1 provides a defined reference. It is a mouse-derived monoclonal antibody of the IgG1 isotype, purified by Protein G, with a concentration of 1 mg/ml.
It reacts with human, mouse, and rat, and is labeled for applications including Western blot, immunohistochemistry on paraffin sections, immunocytochemistry, and immunofluorescence. For studies requiring cross-species expression comparisons, one antibody covering three species reduces batch-to-batch variability from switching antibodies.
| Parameter | Details |
|---|---|
| Product Name | PGK1 Mouse mAb |
| Catalog Number | S0B60368 |
| Host & Antibody Type | Mouse / Mouse mAb (IgG1) |
| Antigen Name | PGK1 |
| Molecular Aliases | Phosphoglycerate kinase 1; Cell migration-inducing gene 10 protein; Primer recognition protein 2 (PRP 2); PGKA |
| Cellular Localization | Cytoplasm, Mitochondrion |
| UniProt Accession | P00558 |
| Reactive Species | Hu, Ms, Rt |
| Purification Method & Concentration | Protein G; 1 mg/ml |
| Label & Form | Unconjugated; Liquid |
| Buffer System | PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide |
| Storage Conditions | 12 months from date of receipt/reconstitution, -20°C as supplied |
| Applications & Dilution Ratios | WB 1:5000-1:50000 (Hu, Ms, Rt); IHC-P 1:2000 (Hu, Ms, Rt); ICC 1:800 (Hu); IF 1:800 (Ms, Rt) |
The validation figures cover seven conditions. Three Western blots used 1:20000 dilution with 1.5-hour room temperature incubation. They resolved A-431, NCCIT, PC-3, HeLa, and Jurkat whole-cell lysates, mouse testis lysate, and rat testis lysate, each at 20 micrograms per lane. The human cell lines show a predicted 45 kDa and an observed 40 kDa. Mouse and rat testis show a predicted 45 kDa and an observed 42 kDa.
Immunohistochemistry at 1:2000 dilution produced positive staining in paraffin-embedded human kidney tissue and in paraffin-embedded human liver cancer tissue. Both used heat-mediated antigen retrieval in Tris/EDTA buffer at pH 9.0 with hematoxylin counterstain. Immunocytochemistry at 1:800 with overnight incubation at 4 degrees Celsius produced positive staining in A431 cells, using cold methanol fixation and 0.1% PBS-Triton X-100 permeabilization. Detection used Alexa Fluor 488 secondary antibody at 1:1000 with DAPI and tubulin counterstains. A tissue expression atlas further documents PGK1 distribution in tumor tissues.
The verifiability of the data is also noteworthy. The product comes with a datasheet and certificate of analysis, with sequence information traceable to UniProt accession P00558. The product page does not provide a reference list. The experimental conditions, dilution ratios, and sample information are all cited from publicly available validation data on the product page.
Summary and Outlook
PGK1 connects three seemingly unrelated things. It links how cells produce ATP, how tumors reprogram metabolism, and how a single enzyme defect can simultaneously affect red blood cells and muscle. Its abundance and localization changes can alter cellular responses to hypoxia and chemotherapy. For metabolic targets with expression differences spanning orders of magnitude, the ideal antibody avoids saturation in high-abundance samples and retains sensitivity in low-abundance samples. It should also maintain consistency across humans and rodents. Such a reagent enables meaningful cross-comparisons. The resolving power of an antibody determines whether metabolic differences are seen or averaged out.
Related Products
PGK1 detection benefits from a reagent that spans high- and low-abundance samples and covers multiple species with one lot. The product below is listed in article order.
| Product Name | Catalog No. |
|---|---|
| PGK1 Mouse mAb | S0B60368 |
Key Features
| Key Advantage | Detailed Parameter / Function |
|---|---|
| Very wide working dilution range | Western blot is validated from 1:5000 to 1:50000 for human, mouse, and rat samples, which accommodates the orders-of-magnitude expression differences that make single-condition PGK1 detection unreliable. |
| Three-species cross-reactivity | Reacts with human, mouse, and rat in one reagent, avoiding the batch-to-batch variability introduced when switching antibodies between model systems. |
| Documented band position deviation | The product page records a predicted 45 kDa against observed values of 40 kDa in human cell lines and 42 kDa in rodent testis, so correct bands are not misread as artifacts. |
| Multi-application validation | Validated for Western blot, immunohistochemistry on paraffin sections at 1:2000, immunocytochemistry at 1:800, and immunofluorescence at 1:800. |
ANT BIO PTE. LTD. maintains a mature antibody development platform that spans antigen design, immunization strategy optimization, high-throughput single B cell sorting, antibody gene cloning, recombinant expression, and multi-application validation. The platform delivers systematic customization solutions for different application scenarios. To learn more about the PGK1 Mouse mAb or to request a sample test, please contact us.
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
